Physician profile
Amram Dahukey
NPI 1366592867
$3,474.22
in general payments reported to CMS, 2019-2025
18 companies · $59.50 in 2025
The $59.50 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,284 · 2020: $559 · 2021: $502 · 2023: $70.07 · 2025: $59.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metric Medical Devices, INC. | $2,043.24 | 2019-2020 | |
| Organogenesis INC. | $203.11 | 2020 | |
| Zimmer Biomet Holdings, INC. | $182.65 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $132.23 | 2021 | |
| Osiris Therapeutics INC. | $128.36 | 2019 | |
| Next Science LLC | $125.00 | 2021 | |
| Flower Orthopedics Coporation | $118.04 | 2021 | |
| Smith+Nephew, INC. | $107.10 | 2019-2023 | Collagenase Santyl |
| Parcus Medical, LLC | $93.32 | 2020 | |
| Anika Therapeutics, INC. | $80.87 | 2021 | |
| Stryker Corporation | $59.50 | 2025 | Prostep Mica |
| Derma Sciences, INC. | $41.65 | 2019 | |
| Orthofix Medical, INC. | $41.23 | 2019-2020 | |
| Averitas Pharma INC. | $40.13 | 2023 | Qutenza |
| Abbvie INC. | $25.50 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.12 | 2021 | |
| Integra Lifesciences Corporation | $19.00 | 2020 | |
| Misonix INC | $13.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amram Dahukey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.